HDAC inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HDAC inhibitor, covering 2009-08-14 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor [Phase 2]